Apollo Hospitals Enterprise

Bangladesh has long been the largest source of medical tourists to India, with a 48 per cent year-on-year (Y-o-Y) surge bringing 449,570 patients in 2023 alone

During the period under review, the company's revenue grew by 15 per cent to Rs 5,086 crore, compared to Rs 4,418 crore during the same quarter last fiscal

Funds are to be utilised for growth capital in AHL, to pay for the Rs 890 cr of the Rs 1290 cr slump sale consideration owed to AHEL, and acquisition of an 11.2 per cent stake in Keimed for Rs 730 cr

The merger will happen in a phased manner over the next 24-30 months. The combined entity is expected to deliver Rs 25,000 crore of revenue in three years with 7-8 per cent EBITDA

Prior to joining Apollo, Sasidhar held various roles at Cleveland Clinic, including President of Cleveland Clinic Tradition Hospital

Free cash flows will enable health care chain to grow, says Suneeta Reddy

Apollo Hospitals on Wednesday said it has acquired a partially built hospital at Sonarpur in West Bengal's South 24 Parganas with a total capacity of 325 beds in a bid to ramp up its healthcare capacity in the Eastern region. Future Oncology Hospital and Research Center was acquired in an all cash deal of Rs 102 crore by Apollo Multispecialty Hospitals Ltd, a wholly owned unlisted subsidiary of Apollo Hospitals Enterprises. The acquisition is being fully funded through its own internal accruals, the company informed the bourses. This will be the second Apollo Hospital in the Kolkata region and fifth in the eastern region. The announcement comes close on the heels of Manipal Hospitals acquiring an 84 per cent stake in AMRI Hospitals Ltd having a total of 1,200 beds in three hospitals at an enterprise valuation of Rs 2,500 crore. "The addition of this new facility is part of our planned capacity expansion across the country and will allow us to serve even more people in the region,"

As compared to 64% in the March quarter, overall occupancies across hospitals in the group were at 62%

Analysts tracking index composition say Apollo Hospitals will replace Indian Oil; official announcement expected by Feb third week, changes will become effective on March 31

Most analysts are positive but target prices indicate limited upside

Structurally, cost reduction drives, expanding of complex procedures and profitability of new hospitals and AHL remain key management focus areas, analysts said.

The government should move quickly to ramp up the availability of the COVID-19 vaccine in the country by enhancing domestic production as well as increasing procurement from abroad, Apollo Hospitals Joint MD Sangita Reddy said on Monday. Reddy also urged the government to utilise all public and private hospitals at the district level for vaccination purposes. "The challenge of India#vaccinationstrategy is not admin as much as supply. I urge R #govt to move quickly on ramping up domestic prod, enhance intl procure, seek Intl aid in the form of vaccine & establish a dist network of all Pub & Pvt hospitals 2 accelerate the pace of inoculation," Reddy said in a post on micro-blogging site Twitter. Last week, Reddy had suggested the government to take decisive actions to ramp up the production of COVID vaccines and streamline the inoculation processes to include citizens who do not have access to the internet. "I urge @PMOIndia 2 take Bold & decisive actions to ramp up #COVID .

The final issue price, including any discount to the floor price, will be determined in the fund-raising committee meeting on January 22, 2021

The pharmacy business is one the main segments that helped Apollo cushion from any big shocks due to the pandemic

Market Ahead, February 13: All you need to know before the Opening Bell

Almost 615 companies, including BPCL, Page Industries, Nestle India, and Apollo Hospitals Enterprise, are scheduled to announce their December quarter results today

The promoter group shareholding in AHEL was around 30.80 per cent at the end of September, 2019, of which around 66.19 per cent is pledged, according to regulatory filing

Promoters say the plan to reduce pledged shares in the firm to 50% in a few months is on track

The company's consolidated net profit more than doubled at Rs 49 crore in Q1FY20 as against a PAT of Rs 23 crore in the year ago quarter.

The stock hits 52-week high of Rs 1,324, up 5%, rallied 43%, as compared to 3% rise in the S&P BSE Sensex during past six months.

Targets Rs 100 billion revenue in the next five years